New York, NY
Gilgamesh is a pioneering early-stage biotech developing novel compounds that build upon the benefits of classic psychedelics with improvements of other components such as safety, tolerability, duration, and efficacy. Mental health worldwide has reached epidemic proportions and novel treatments have not kept pace with the urgent need to treat depression, anxiety, drug addiction and many other devastating diseases. Our purpose is to accelerate treatments and fundamentally improve mental health.
gilgameshpharmaceutical.comThese are collections Gilgamesh Pharmaceuticals is a part of. Click on the collection name to view similar companies.
Grant
$14,000,000
Series B
$39,000,000
Series A
$27,000,000
Seed
$125,000
Seed
$2,434,845
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Gilgamesh Pharmaceuticals.